![Brent Warner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brent Warner
Geen lopende functies
Vermogen: 1 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Brent Warner
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Brent Warner via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
FirstMark Capital LLC
![]() FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
Odyssey Therapeutics, Inc.
![]() Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
Demeetra AgBio, Inc.
![]() Demeetra AgBio, Inc. Miscellaneous Commercial ServicesCommercial Services Demeetra AgBio, Inc. is an American biotechnology company that specializes in gene editing. Demeetra AgBio is located in a hub for agbiotech and is centrally located in the bluegrass state. The company has built extensive gene editing know-how and has a scientific team composed of experts with diverse backgrounds in gene editing. The company's scientific achievements include being the first to successfully edit plants and yeast with their precise cas-clover technology. Demeetra AgBio's primary focus is on engineering traits for life with advanced gene-editing technologies cas-clover & piggybac transposase. The company was founded in 2019 by Eric M. Ostertag and is currently led by CEO Jack Crawford. | Miscellaneous Commercial Services | Founder | |
Colorado BioScience Association
![]() Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Director/Board Member | |
Tufts University | College/University | Graduate Degree | |
United States Naval Academy | College/University | Undergraduate Degree | |
MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Washington University School of Medicine | College/University | Doctorate Degree | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
Oncomyx Therapeutics, Inc.
![]() Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Packaged Software | Chairman | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Vindico NanoBioTechnology LLC
![]() Vindico NanoBioTechnology LLC BiotechnologyHealth Technology Vindico NanoBioTechnology LLC develops novel and life-saving therapies. The company is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer | |
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Seville | College/University | Doctorate Degree | |
Amgen Ltd.
![]() Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ALLOGENE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Corporate Officer/Principal | |
ZAI LAB LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer | |
Adaptimmune LLC
![]() Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of California, Berkeley | College/University | Doctorate Degree | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Celiac Disease Foundation | Director/Board Member | ||
Hera BioLabs
![]() Hera BioLabs Miscellaneous Commercial ServicesCommercial Services Hera BioLabs is a preclinical service and technology provider that offers genetic engineering and animal model creation technologies. Hera conducts all work with excellent scientific rigor and customer service at their laboratories, which include an AAALAC-accredited state-of-the-art vivarium, centrally located in Kentucky. The American company created the SRG™ rat, the first commercially available highly immunocompromised rat model validated for human tumor xenograft studies. Hera has its own proprietary genetic engineering technologies, the PiggyBac® DNA delivery system and the Cas-CLOVER™ site-specific nuclease system platforms used for cell line modification and animal model creation. The company provides researchers in industry and academia with genetic engineering technologies and related products, as well as services in these areas, performing cell engineering and in vitro and in vivo oncology studies for clients. The company was founded by Eric M. Ostertag. | Miscellaneous Commercial Services | Founder | |
University of Pennsylvania | College/University | Doctorate Degree | |
Transposagen Biopharmaceuticals, Inc.
![]() Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Biotechnology | Chief Executive Officer | |
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Longitude Capital Management Co LLC
![]() Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | Investment Managers | Founder | |
Civitas Therapeutics, Inc.
![]() Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
Helomics Corp.
![]() Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Director/Board Member | |
Zavante Therapeutics, Inc.
![]() Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
TRICIDA, INC. | Pharmaceuticals: Major | Director/Board Member | |
MOLECULAR TEMPLATES, INC. | Biotechnology | Director/Board Member | |
Inflazome Ltd.
![]() Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
PREDICTIVE ONCOLOGY INC. | Medical Specialties | Director/Board Member | |
Alpha-9 Oncology, Inc.
![]() Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
Hera Testing Laboratories, Inc.
![]() Hera Testing Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Hera Testing Laboratories, Inc. develops preclinical drugs for vivo and vitro toxicology. The company was founded in 2014 and is headquartered in Lexington, KY. | Pharmaceuticals: Major | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 44 |
Verenigd Koninkrijk | 4 |
Spanje | 2 |
China | 2 |
Ierland | 2 |
Sectoraal
Health Technology | 24 |
Consumer Services | 10 |
Commercial Services | 7 |
Finance | 6 |
Health Services | 4 |
Operationeel
Director/Board Member | 31 |
Corporate Officer/Principal | 15 |
Independent Dir/Board Member | 11 |
Chief Tech/Sci/R&D Officer | 9 |
Doctorate Degree | 7 |
Sterkste connecties
Insiders | |
---|---|
David Hirsch | 20 |
Matthew A. Spear | 12 |
Charles Baum | 12 |
Eric Ostertag | 9 |
Rafael Amado | 9 |
Kristin Yarema | 7 |
Kerry Ingalls | 4 |
- Beurs
- Insiders
- Brent Warner
- Bedrijfsconnecties